NEWS IN BRIEF
LabConnect completes phase one of expansion to up PBMC capabilities
LabConnect has completed phase one of three to increase its capacity for peripheral blood mononuclear cell (PBMC) processing at its facility in Johnson City, TN.
Archives for May 24, 2018
Lonza grows hepatocytes portfolio
Lonza has added to its hepatocytes portfolio to provide researchers with the foundation to create “more physiologically relevant” in vitro models for liver disease research.
How big data can design safer clinical trials and reduce animal testing
Bayer AG and Elsevier studied more than 1.6m adverse events to show how big data can be used to reduce animal testing and design trials "altered to potential risks," says researcher.
Catalent-made Lucemyra wins US FDA approval for opioid withdrawal
The US FDA has approved US WorldMeds LLC’s non-opioid treatment Lucemyra, adding another “tool to the toolbox” for withdrawal management, says American Society of Addiction Medicine.
Dr Reddy’s prepares for Duvvada re-inspection following Form 483
Dr Reddy’s expects to have addressed all GMP violations at its Duvvada drug formulation plant and Srikakulam API facility within the next six weeks, says CEO.
INTERPHEX 2018
Continuous manufacturing: Lower API volumes reduce development costs, says exec
Continuous manufacturing can help drugmakers save on development costs by reducing API waste, says Trek Therapeutics’ Kevin Bittorf.